Efluelda Tetra

Efluelda Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. This vaccine is suitable for intramuscular or subcutaneous use and is manufactured by Sanofi Winthrop Industrie.

Efluelda Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the B/Michigan/01/2021 virus. This vaccine is typically administered to individuals seeking protection against seasonal flu strains. It is important to consult with a healthcare provider to determine if this vaccine is appropriate for your specific needs.

Common effects of Efluelda Tetra may include mild soreness or redness at the injection site. Some individuals may experience temporary discomfort, fatigue, or low-grade fever following vaccination. These effects are generally mild and short-lived.

Efluelda Tetra should be handled and stored according to the manufacturer's guidelines to maintain its effectiveness. Individuals with a history of severe allergic reactions to previous flu vaccines or any of the vaccine components should exercise caution. Always inform your healthcare provider about any existing medical conditions or allergies before receiving the vaccine.

Efluelda Tetra may interact with certain medications or health conditions. It is important to discuss your current medications and health status with a healthcare provider before receiving this vaccine. Avoid alcohol consumption immediately before and after vaccination, as it may affect the body's response to the vaccine.